Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug 26.
doi: 10.1007/s00270-025-04176-7. Online ahead of print.

Comments on: "Prognostic Performance of Model for End-Stage Liver Disease (MELD) 3.0 for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation" by Michimoto et al. (2025)

Maria Del Pilar Bayona Molano  1 , Gabriel Perreault  2
Affiliations
Editorial

Comments on: "Prognostic Performance of Model for End-Stage Liver Disease (MELD) 3.0 for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation" by Michimoto et al. (2025)

Maria Del Pilar Bayona Molano et al. Cardiovasc Intervent Radiol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: No conflict of interest. Ethical approval: Not required. Informed consent: Not required. Consent for publication: Not applicable.

References

    1. Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL, Gentry SE, Kwong AJ. MELD 3.0: the model for end-stage liver disease updated for the modern era. Gastroenterology. 2021;161(6):1887–95. https://doi.org/10.1053/j.gastro.2021.08.050 . - DOI - PubMed
    1. Michimoto K, Campos L, Cushen S, Suzuki T, Yamada K, Naugler W, Farsad K. Prognostic performance of model for end-stage liver disease (MELD) 3.0 for transjugular intrahepatic portosystemic shunt (TIPS) creation. Cardiovasc Intervent Radiol. 2025. https://doi.org/10.1007/s00270-025-04116-5 . - DOI - PubMed
    1. Song J, Wang X, Yan Y, Xiang T, Luo X. MELD 3.0 score for predicting survival in patients with cirrhosis after transjugular intrahepatic portosystemic shunt creation. Dig Dis Sci. 2023;68(7):3185–92. https://doi.org/10.1007/s10620-023-07834-3 . - DOI - PubMed
    1. Flynn M, Parekh A, Spiritos Z, Bartnik C, Mallepally N, Ermentrout R, Kies D, Subramanian R. The safety of TIPS in high MELD patients: re-examining established practices: 1023. Am J Gastroenterol. 2017;112:S570–1.
    1. Wint T, Badar W, Kadkol SS, Gaba RC. Comparative prognostic utility of updated model for end-stage liver disease scores for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol. 2025;36(7):1125–32. https://doi.org/10.1016/j.jvir.2025.03.023 . - DOI - PubMed

Publication types

LinkOut - more resources